PRNP and colonic neoplasm: Treating human colon cancer stem cells (CSCs) with 500 μM melatonin and 1 μM 5-fluorouracil (5-FU) caused apoptosis and inhibited expression of the stem cell marker Oct4 by inhibition of PrPC expression [115].